2-pyridin-4-yl-butyric acid | 748708-00-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-pyridin-4-yl-butyric acid
• 英文别名: 2-[4]pyridyl-butyric acid；2-[4]Pyridyl-buttersaeure；ethyl 4-pyridyl acetic acid；4-pyridine butyric acid；ethyl pyridin-4-yl acetic acid；2-pyridin-1-ium-4-ylbutanoate
• CAS: 748708-00-1
• 化学式: C₉H₁₁NO₂
• 分子量: 165.192
• InChiKey: YQORMSBFOZKIPW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  54.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-pyridin-4-yl-butyric acid 在 重水 、 4-羟乙基哌嗪乙磺酸 作用下， 反应 48.0h， 生成
  参考文献：
  名称：

  工程化丙二酸丙二酸脱羧酶的混杂消旋酶活性

  摘要：

  支气管败血波氏杆菌中的芳基丙二酸脱羧酶（AMDase）G74C变体对profens具有独特的消旋作用。通过蛋白质工程，基于脱羧反应的活性降低和消旋活性的两倍提高，获得了向混杂消旋化20倍的变体G74C / V43A。该突变体显示出扩大的底物范围，对酮洛芬的反应速率提高了30倍。分子动力学模拟和消旋酶的底物特征表明，底物结构的空间和极性效应在催化方面比单纯的动力学α-质子酸度起着更大的作用。β，γ-不饱和羧酸的转化不会导致重排形成其α，β异构体的观察结果表明，这是一个协调的机制，而不是逐步的机制。有趣的是，

  DOI：

  10.1002/chem.201001924
• 作为产物：
  描述：

  5-乙基-5-吡啶-4-基-嘧啶-2,4,6-三酮 在 ammonium hydroxide 、 碳酸氢铵 作用下， 生成 2-pyridin-4-yl-butyric acid
  参考文献：
  名称：

  DE638821

  摘要：

  公开号：

文献信息

• Tricyclic amide and urea compounds useful for inhibition of G-protein
  申请人：Schering Corporation

  公开号：US05700806A1

  公开（公告）日：1997-12-23

  Novel compounds of Formula (7.0a), (7.0b) or (7.0c): ##STR1## are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula (7.0a), (7.0b) or (7.0c) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.

  揭示了化合物的新颖结构，其化学式为(7.0a)、(7.0b)或(7.0c)：##STR1##。还揭示了一种抑制Ras功能从而抑制细胞异常生长的方法。该方法包括向生物系统施用化合物的化学式(7.0a)、(7.0b)或(7.0c)。具体而言，该方法抑制了哺乳动物（如人类）中细胞的异常生长。
• Tricyclic compounds
  申请人：Schering Corporation

  公开号：US05891872A1

  公开（公告）日：1999-04-06

  Novel compounds of Formula ##STR1## are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.

  揭示了化学式##STR1##的新化合物。还揭示了一种抑制Ras功能从而抑制细胞异常生长的方法。该方法包括向生物系统施用该化合物。具体来说，该方法抑制了哺乳动物（如人类）中细胞的异常生长。
• Tricyclic amide and urea compounds useful for inhibition of g-protein
  申请人：Schering Corporation

  公开号：US05719148A1

  公开（公告）日：1998-02-17

  A method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells is disclosed. The method comprises the administration of a compound of Formula 1.0: ##STR1## to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being. Novel compounds of formulas 5.0, 5.1 and 5.2, wherein R is --C(R.sup.20)(R.sup.21)(R.sup.46), and 5.3, 5.3A and 5.3B, wherein R is --N(R.sup.25)(R.sup.48), are disclosed. Also disclosed are processes for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3. Further disclosed are novel compounds which are intermediates in the process for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3.

  抑制Ras功能从而抑制细胞异常生长的方法已被披露。该方法包括向生物系统中施用Formula 1.0的化合物：##STR1##。具体来说，该方法抑制了哺乳动物（如人类）中细胞的异常生长。还披露了Formula 5.0、5.1和5.2的新化合物，其中R为--C(R.sup.20)(R.sup.21)(R.sup.46)，以及Formula 5.3、5.3A和5.3B，其中R为--N(R.sup.25)(R.sup.48)。还披露了制备Formula 5.0、5.1、5.2和5.3的3-取代化合物的方法。此外，还披露了在制备Formula 5.0、5.1、5.2和5.3的3-取代化合物过程中的中间体新化合物。
• Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
  申请人：——

  公开号：US20030055065A1

  公开（公告）日：2003-03-20

  A method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells is disclosed. The method comprises the administration of a compound of Formula 1.0: 1 to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being. Novel compounds of the formulas 2 are disclosed. Also disclosed are processes for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3. Further disclosed are novel compounds which are intermediates in the process for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3.

  本发明揭示了一种抑制Ras功能，从而抑制细胞异常生长的方法。该方法包括向生物系统中给予1.0:1式化合物。特别是，该方法抑制哺乳动物（如人类）中细胞的异常生长。本发明还揭示了新的2式化合物。还揭示了制备5.0、5.1、5.2和5.3式3-取代化合物的方法。本发明还揭示了制备3-取代化合物5.0、5.1、5.2和5.3式的中间体。
• Benzofuran derivative
  申请人：Kawaguchi Takayuki

  公开号：US20050282808A1

  公开（公告）日：2005-12-22

  The present invention provides a benzofuran derivative of the formula [1]: wherein x is a group of the formula: —N═ or —CH═; Y is an optionally substituted amino group, an optionally substituted cycloalkyl group or an optionally substituted saturated heterocyclic group; A is a single bond, a carbon chain optionally having a double bond within or at the end(s) of the chain, or an oxygen atom; R 1 is a hydrogen atom or a halogen atom; Ring B is an optionally substituted benzene ring; and R 3 is a hydrogen atom, or a pharmaceutically acceptable salt thereof, which is useful as a medicament, especially as an activated blood coagulation factor X inhibitor.

  本发明提供了一种苯并呋喃衍生物，其化学式为[1]：其中x是公式：—N═或—CH═的基团；Y是可选取的取代氨基、可选取的取代环烷基或可选取的饱和杂环基团；A是单键、可选取的具有双键或位于链的末端的碳链或氧原子；R1是氢原子或卤素原子；环B是可选取的取代苯环；R3是氢原子或其药学上可接受的盐，该化合物作为药物特别是激活的血凝血因子X抑制剂。